Aruspex Announces Release 5.1 of the Aruspex Strategic Workforce Planning Tool

Incorporate your future business plan data into your scenario demand models — Introducing the Demand Driver Integration. Make use of your sales forecast, expansion plan or growth target data!

San Francisco, Calif. / Jan 1st, 2011 — Aruspex, the only company focused solely on strategic workforce planning, today announced general availability of version 5.1 of their leading strategic workforce planning software.

The world's most successful companies — including Starbucks Coffee Company — partner with Aruspex to plan and build their best workforce. Aruspex's software analyzes internal and external workforce trends and guides effective planning to ensure that companies have the workforce agility to meet current and future business demands.

"There are many factors which affect the demand forecast within your strategic workforce plan, why not use business information that already exists?
Demand Driver information could include sales forcasts, expansion plans, production expectations, any data which the business has that will affect the future demand for staff "

Release 5.1 of the Aruspex Strategic Workforce Planning tool is generally available now. For more information, visit http://www.aruspex.com/solutions_planning.html\

About Aruspex
Aruspex is the only company solely focused on strategic workforce planning, helping the world's largest companies plan and build the right workforce to meet their strategic objectives. Aruspex's software analyzes internal and external workforce trends to ensure that companies are completely prepared to meet current and future business demands. The Aruspex approach was developed through years of practical experience. Aruspex's workforce planning software is a proprietary quantitative and qualitative workforce assessment and planning system that guides the company in planning and build future workforces. The system is complemented by Aruspex Advisory Programs that provide clients with hands-on education and ongoing guidance. For more information, visit www.aruspex.com.